Panbela Therapeutics Inc. (PBLA) - Analysis

0.020000000 USD

0.0089

80.18%

Last update Oct 31, 2:40 PM EDT

Market closed

Day range

0.020000000

0.015550000

0.020000000

Previous close

0.011100000

Open

0.015550000

Access this stock data via API

Panbela Therapeutics Inc.

0.02

0.01

80.18%

Analysis

Revenue estimate	Next year (Dec 2025)
Number of Analysts	0
Avg. estimate	0
Low estimate	0
High estimate	0
Last year sales	—
Sales growth	—

Access /revenue_estimate data via our API — starting from the Ultra plan.

EPS trend	Next year (Dec 2025)
Current estimate	0
7 days ago	0
30 days ago	0
60 days ago	0
90 days ago	0

Access /eps_trend data via our API — starting from the Ultra plan.

EPS revisions	Next year (Dec 2025)
Up last 7 days	0
Up last 30 days	0
Down last 7 days	0
Down last 30 days	1

Access /eps_revisions data via our API — starting from the Ultra plan.

Analyst ratings

Firm	Date	Action
HC Wainwright & Co.	Aug 15, 2024	Reiterates
HC Wainwright & Co.	Jun 24, 2024	Reiterates
HC Wainwright & Co.	May 16, 2024	Downgrade
HC Wainwright & Co.	Apr 02, 2024	Maintains
Roth MKM	Mar 27, 2024	Maintains
Roth MKM	Feb 05, 2024	Maintains
Roth MKM	Dec 18, 2023	Reiterates
HC Wainwright & Co.	Aug 11, 2023	Reiterates
HC Wainwright & Co.	Jul 24, 2023	Reiterates
HC Wainwright & Co.	Jul 10, 2023	Reiterates
HC Wainwright & Co.	Jun 13, 2023	Reiterates
HC Wainwright & Co.	Jun 02, 2023	Reiterates
HC Wainwright & Co.	May 05, 2023	Reiterates
HC Wainwright & Co.	Apr 26, 2023	Initiates
Maxim Group	Mar 20, 2023	Upgrade
Roth Capital	Jan 31, 2023	Reinstates
Maxim Group	Oct 12, 2022	Downgrade
Roth Capital	Jun 28, 2021	Initiates
Maxim Group	Mar 10, 2021	Initiates

Access /analyst_ratings/light data via our API — starting from the Ultra plan.